Author： Adis International Limited
Publisher： Adis International
ISSN： 1174-5886
Source： Drugs in R&D, Vol.5, Iss.6, 2004-01, pp. : 363-367
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
CCI 779 active in refractory metastatic renal cancer
Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. :
Access to resources
Recommend
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme
By Chang Susan Wen Patrick Cloughesy Timothy Greenberg Harry Schiff David Conrad Charles Fink Karen Robins H. Angelis Lisa Raizer Jeffrey Hess Kenneth Aldape Ken Lamborn Kathleen Kuhn John Dancey Janet Prados Michael
Investigational New Drugs, Vol. 23, Iss. 4, 2005-08 ,pp. :
Temsirolimus: In Advanced Renal Cell Carcinoma
By Simpson Dene Curran Monique P.
Drugs, Vol. 68, Iss. 5, 2008-01 ,pp. :
Temsirolimus: In Relapsed and/or Refractory Mantle Cell Lymphoma
By Hoy Sheridan M. McKeage Kate
Drugs, Vol. 70, Iss. 14, 2010-10 ,pp. :